Establishment profile
GENENTECH
325 DNA WAY, SOUTH SAN FRANCISCO, CA, 94080
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Summary
GENENTECH has accumulated 21 OSHA violations across 15 inspections over 34 years of recorded history, with $20,600 in total assessed penalties.
The establishment sits in the 99th percentile for violations within its industry-state peer group of 168 employers. Inspection frequency runs at the 100th percentile. The most recent enforcement activity was recorded 10 months ago.
Federal records were found in 1 of 15 sources. Sources without matching records returned empty for this establishment.
Agency coverage
GENENTECH appears in OSHA workplace safety, EPA environmental compliance, OFLC visa and labor certification (historical), FMCSA motor carrier registration, and CPSC product recalls records only. No matching records were found in WHD wage enforcement, MSHA mine safety, NLRB labor relations, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, or NHTSA vehicle recalls.
OSHA workplace safety
53% of inspections at this establishment produced violations, with 2 inspections producing serious-or-greater violations.
Most-cited OSHA standards
Top OSHA standards cited at this employer, ranked by citation count. Standards (CFR sections) cluster citations into safety themes -- machine guarding, lockout-tagout, hazard communication, fall protection, process safety, etc. A concentration on one or two sections reveals a pattern that individual citations don’t. 19 distinct standards shown · 21 citations in this view · $20,600 in penalties.
| CFR section | Citations | Inspections | Total penalty | First cited | Last cited |
|---|---|---|---|---|---|
| 5194 F04 | 2 | 2 | $325 | Jul 1997 | Sep 1998 |
| 5194 H01 | 2 | 2 | $300 | Sep 1998 | May 2009 |
| 5157 D03 C | 1 | 1 | $5,060 | Jun 2003 | Jun 2003 |
| 5157 J05 | 1 | 1 | $5,060 | Jun 2003 | Jun 2003 |
| 5157 D03 B | 1 | 1 | $5,060 | Jun 2003 | Jun 2003 |
| 4002 A | 1 | 1 | $1,125 | Jul 1997 | Jul 1997 |
| 5002 | 1 | 1 | $750 | Jul 1997 | Jul 1997 |
| 5191 F01 | 1 | 1 | $600 | Jul 1997 | Jul 1997 |
| 5157 D05 A | 1 | 1 | $560 | Jun 2003 | Jun 2003 |
| 5157 J02 | 1 | 1 | $560 | Jun 2003 | Jun 2003 |
| 5144 C01 | 1 | 1 | $300 | May 2009 | May 2009 |
| 5164 A | 1 | 1 | $300 | Jan 1997 | Jan 1997 |
| 6151 C01 | 1 | 1 | $150 | Jun 2002 | Jun 2002 |
| 3235 M02 | 1 | 1 | $150 | Jun 2002 | Jun 2002 |
| 5202 F03 B | 1 | 1 | $150 | Jun 2002 | Jun 2002 |
| 5202 L01 | 1 | 1 | $150 | Jun 2002 | Jun 2002 |
| 3203 A | 1 | 1 | — | Dec 1991 | Dec 1991 |
| 3272 B | 1 | 1 | — | Dec 1991 | Dec 1991 |
| 3241 C | 1 | 1 | — | Dec 1991 | Dec 1991 |
Source: OSHA inspection citations (violation_detail). CFR section codes can be looked up at osha.gov/laws-regs for the formal standard text. Per-inspection detail and the specific violation descriptions are available by expanding individual inspections below.
Peer comparison
Worse on violations than nearly every other employer in NAICS 5417 within CA. Peer group: 168 employers. This establishment has 21 OSHA violations; peer median is 1.
Safety self-report (OSHA 300A)
Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.
Reported for 12,651 average annual employees at this establishment.
Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.
Industry benchmark
BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.
Inspection breakdown
Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.
OSHA severe injury reports
No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for GENENTECH. Verify directly with Occupational Safety and Health Administration →
OSHA accident events
Accidents, fatalities, and catastrophes documented during OSHA inspections at this employer. Each entry links to the inspection that recorded it.
| Date | Event | Injuries | Hospitalized | Fatalities | |
|---|---|---|---|---|---|
| Apr 26, 2012 | FRACTURE,SLIP,WALKING SURFACE,FALL,SLIPPERY SURFACE,LOST BALANCE,LEG,WATER | 1 | 1 | — |
Source: OSHA accident investigations. Narratives are recorded by the inspecting officer and may be truncated.
Activity timeline
Most recent federal enforcement activity recorded 10 months ago. Data on this page is refreshed weekly.
Wage & Hour Division (WHD)
No WHD wage, overtime, or child-labor enforcement cases on file for GENENTECH. Verify directly with Wage and Hour Division →
Mine safety (MSHA)
No MSHA mine safety violations on file for GENENTECH. Verify directly with Mine Safety and Health Administration →
Labor relations (NLRB)
No NLRB unfair labor practice charges or union representation cases on file for GENENTECH. Verify directly with National Labor Relations Board →
Visa & labor certification (OFLC) — historical
Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage. Historical data only: DOL ended OFLC Performance Data Disclosure publication in 2026, so the figures above reflect filings through the last ingested cycle and are not being refreshed. Treat as a historical snapshot, not a current signal.
Environmental compliance (EPA)
EPA Enforcement and Compliance History — Clean Air Act, Clean Water Act, RCRA, Safe Drinking Water Act. Status: No Violation Identified.
EPA-registered facilities
Every EPA ECHO facility associated with this employer, sorted most-significant first. Each row links to EPA’s Detailed Facility Report for the source-of-truth record. Permits column lists active programs (Air = Clean Air Act, Water = Clean Water Act, RCRA = hazardous waste, TRI = Toxics Release Inventory reporting). 5 facilities · 1 marked inactive.
| Facility | Permits | Status | Inspections | Formal actions | Penalties | Last inspected | ECHO |
|---|---|---|---|---|---|---|---|
GENENTECH INC 460 POINT SAN BRUNO BOULEVARD · SOUTH SAN FRANCISCO, CA, 94080 | AirWater | No Violation Identified | 3 | 0 | — | Feb 2025 | View → |
GENENTECH INC 611 GATEWAY BOULEVARD · SOUTH SAN FRANCISCO, CA, 94080 | RCRA | No Violation Identified | 0 | 0 | — | — | View → |
GENENTECH INC 530 FORBES BLVD · S SAN FRANCISCO, CA, 94080 | RCRA | No Violation Identified | 0 | 0 | — | — | View → |
GENENTECH INC 333 POINT SAN MATEO BLVD · SOUTH SAN FRANCISCO, CA, 94080 | RCRA | No Violation Identified | 0 | 0 | — | — | View → |
GENENTECH, INC. 301 EAST GRAND AVENUE · SOUTH SAN FRANCISCO, CA, 94080 | RCRA | No Violation Identified | 0 | 0 | — | — | View → |
Source: EPA ECHO (Enforcement and Compliance History Online). Compliance status follows EPA’s own labels (“Sig Violation” = significant noncompliance; QNCR = quarters of noncompliance over the recent reporting window). Inactive facilities (struck through) retain historical enforcement records even after operations ceased.
Motor carrier safety (FMCSA)
Federal Motor Carrier Safety Administration — DOT-regulated carrier registration and fleet data.
Federal criminal prosecution record
No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for GENENTECH. Verify directly with UVA Corporate Prosecution Registry →
CPSC product recalls
Top hazard: The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).. Most recent recall: 2021-03-18. Source: Consumer Product Safety Commission, matched on company name.
CPSC recall roster
Every CPSC consumer-product recall associated with this manufacturer, most-recent first. Hazards reflect CPSC’s classification (laceration, fire, fall, choking, lead exposure, etc.). Each row links to the agency’s authoritative recall page for the full remedy / contact / recall-number detail. 1 recall shown · 1 distinct hazard categories.
| Recall | Date | Hazards | Units | CPSC |
|---|---|---|---|---|
Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Drug Exposure through Eye or Skin Absorption (Recall Alert) #21729 | Mar 2021 | The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA). | — | View → |
Source: Consumer Product Safety Commission. Recall details (specific products, sale dates, remedy instructions) live on the cpsc.gov record linked from each row.
Federal contracts
This location
Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.
Federal contract dollars to this establishment. Primary NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). Last action: 2026-06-11. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.
Inspection history
| Date | Trigger | Violations | Serious | Penalty | |
|---|---|---|---|---|---|
| 2025-09-22 | Accident | 0 | — | $0 | |
| 2015-12-02 | Complaint | 0 | — | $0 | |
| 2012-05-09 | Accident | 0 | — | $0 | |
| 2009-03-25 | Complaint | 2 | — | $600 | |
| 2009-03-04 | Complaint | 0 | — | $0 | |
| 2003-12-03 | Complaint | 0 | — | $0 | |
| 2003-01-16 | Unprogrammed Related | 5 | 2 | $16,300 | |
| 2002-05-28 | Complaint | 2 | — | $300 | |
| 2002-04-02 | Complaint | 2 | — | $300 | |
| 2002-04-02 | Complaint | 0 | — | $0 | |
| 1998-07-08 | Complaint | 0 | — | $0 | |
| 1998-05-13 | Complaint | 2 | — | $175 | |
| 1997-01-17 | Planned | 4 | 2 | $2,625 | |
| 1996-07-22 | Referral | 1 | — | $300 | |
| 1991-12-19 | Complaint | 3 | — | $0 |
Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.
In the news
Other employers in this industry and state
Other employers in research and development in biotechnology (except nanobiotechnology) within CA, ordered by federal enforcement volume:
- THE SCRIPPS RESEARCH INSTITUTELA JOLLA — 1 federal enforcement record
- ARCADIS-US, INC.THOUSAND OAKS — 1 federal enforcement record
- PACIFIC BIOSCIENCES OF CALIFORNIA, INCMENLO PARK — 1 federal enforcement record
- AMGEN INC.SOUTH SAN FRANCISCO — 1 federal enforcement record
- PAREXEL INTERNATIONAL (MA) CORPORATIONGLENDALE — 1 federal enforcement record
- SANTA CRUZ BIOTECHNOLOGY INCSANTA CRUZ — 1 federal enforcement record
- PHOENIX AGROTECH LLCSANTA ANA — 1 federal enforcement record
Related searches
- Research and Development in Biotechnology (except Nanobiotechnology)All employers in this industry
- Employers in CAState-wide enforcement data
- Research and Development in CAIndustry × state cross-filter
About this data
This profile aggregates federal enforcement records on GENENTECH from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.
Establishments are matched across agencies using normalized employer name, state, and ZIP code.
OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.
Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.
Contact sales →Frequently asked
- What is GENENTECH's OSHA violation history?
- GENENTECH has 15 OSHA inspections on record with 21 violations and $20,600 in total penalties.
- How does GENENTECH's safety record compare to its industry?
- GENENTECH operates in the research and development in biotechnology (except nanobiotechnology) industry. The industry average Total Recordable Incident Rate (TRIR) is 0.6. GENENTECH's self-reported DART rate is 0.4 compared to an industry average of 0.3.